Diagnostic Approach for Suspected Advanced Gallbladder Cancer

Critical Principles for Diagnosis

The American Gastroenterological Association recommends that in suspected advanced gallbladder cancer, MRI with MRCP should be performed first to assess resectability before any percutaneous biopsy is considered, due to the risk of tumor seeding that can convert potentially curable disease into incurable disease 1, 2, 3
Percutaneous biopsy is not recommended for potentially resectable disease due to the risk of tumor seeding along the needle tract, which can eliminate the possibility of curative surgery, directly impacting mortality and quality of life, as suggested by the National Comprehensive Cancer Network 1, 2, 3

Combined MRI and MRCP is the optimal initial investigation for suspected advanced gallbladder cancer, providing comprehensive information on liver and biliary anatomy, local tumor extent, hepatic parenchymal abnormalities, liver metastases, vascular involvement, and bile duct invasion, with a Grade B recommendation from the European Society of Gastrointestinal Endoscopy 4, 3
High-resolution contrast CT should also be obtained to detect distant metastases, particularly in lungs and bone, with a Grade B recommendation from the American College of Radiology 4
Chest imaging should be performed to exclude pulmonary metastases, as recommended by the National Comprehensive Cancer Network 2, 5
Laparoscopy should be considered to detect peritoneal or superficial liver metastases in patients who appear resectable on imaging, as suggested by the Society of Surgical Oncology 2, 5

Tissue diagnosis should only be obtained if the patient is deemed unresectable based on imaging findings, or if biopsy is needed for planning palliative chemotherapy, as recommended by the American Society of Clinical Oncology 1, 2, 3
Biopsy can be obtained via ERCP brushings/cytology, which is safer than the percutaneous approach, though sensitivity is only 30-50%, as noted by the American Gastroenterological Association 1, 4
Biopsy can also be obtained at laparoscopy or laparotomy during surgical assessment, as suggested by the Society of Surgical Oncology 1, 2

Abdominal ultrasonography is recommended as the first‑line screening test for any patient with suspected gallbladder carcinoma, providing a rapid, non‑invasive assessment of gallbladder morphology and the presence of gallstones. This recommendation carries a Grade C strength from multiple guideline societies (Gut 2002)【6】.

Contrast‑enhanced high‑resolution CT should be performed to evaluate distant metastatic spread (particularly pulmonary and skeletal sites) and to delineate vascular involvement, complementing MRI/MRCP findings. This recommendation is assigned a Grade B strength by the same guideline societies (Gut 2002)【7】.

Serum levels of CA 19‑9, CEA, and CA‑125 may be measured to provide adjunctive diagnostic and prognostic information, but they should not be used alone for diagnosis because of limited specificity and potential elevation in benign biliary obstruction. This guidance is supported by the guideline societies (Gut 2002)【8】.